Publications by authors named "Alethea Cope"

Claim this Profile
S
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.
Jonathan A Robbins, Dereck Tait, Qinlei Huang, Sheri Dubey, Tami Crumley, Alethea Cope

EBioMedicine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety and Immunogenicity of GTUMultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART.
G Haidari, Suzanne Day, M Wood, H Ridgers, Alethea V Cope

Front Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.
Yuka Nadai, Kathrin Held, Sarah Joseph, Mohamed I M Ahmed, Verena S Hoffmann, Alethea V Cope

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability and feasibility study of patient-specific 'tumouroids' as personalised treatment screening tools: Protocol for prospective tissue and data collection of participants with confirmed or suspected renal cell carcinoma.
Maxine G B Tran, Joana B Neves, Katerina Stamati, Patricia Redondo, Alethea Cope

Int J Surg Protoc· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine.
Hannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, Sue Fleck, Aleisha Miller, Alethea Cope

Hum Gene Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunity.
Thushan I de Silva, Victoria Gould, Nuredin I Mohammed, Alethea Cope, Adam Meijer

J Immunol Methods· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre.
Victoria M W Gould, James N Francis, Katie J Anderson, Bertrand Georges, Alethea V Cope

Front Microbiol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
Catherine A Cosgrove, Charles J Lacey, Alethea V Cope, Angela Bartolf, Georgina Morris

PLoS One· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes.
Sarah Joseph, Killian Quinn, Aldona Greenwood, Alethea V Cope, Paul F McKay

Front Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
Roger Le Grand, Nathalie Dereuddre-Bosquet, Stefania Dispinseri, Leslie Gosse, Delphine Desjardins, Alethea Cope

J Virol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates.
Xiaoying Shen, Ryan Duffy, Robert Howington, Alethea Cope, Shanmugalakshmi Sadagopal

J Virol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.
Paul F McKay, Alethea V Cope, Jamie F S Mann, Sarah Joseph, Mariano Esteban

PLoS One· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes.
Jamie F S Mann, Paul F McKay, Anezka Fiserova, Katja Klein, Alethea Cope

J Virol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally.
David J Lewis, Carol A Fraser, Abdel N Mahmoud, Rebecca C Wiggins, Maria Woodrow, Alethea Cope

PLoS One· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation.
Martin P Cranage, Carol A Fraser, Alethea Cope, Paul F McKay, Michael S Seaman

Vaccine· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.
Roland R Regoes, E Frances Bowen, Alethea V Cope, Dehila Gor, Aycan F Hassan-Walker

Proc Biol Sci· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope.
Sally A Sharpe, Alethea Cope, Stuart Dowall, Neil Berry, Claire Ham

J Gen Virol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
Jasjit Gill, Dimitra Bourboulia, John Wilkinson, Peter Hayes, Alethea Cope

J Acquir Immune Defic Syndr· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
John Wilkinson, Alethea Cope, Jas Gill, Dimitra Bourboulia, Peter Hayes

J Virol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis